582 Companies
French biotechnology company Innate Pharma S.A. is making strides in the field of immunotherapy for cancer treatment. Its portfolio includes several products, such as Lacutamab (IPH4102), a KIR3DL2...
Healthcare Biotechnology NASDAQ 201-500San Diego-based TRACON Pharmaceuticals, a biopharmaceutical company, is dedicated to developing and commercializing cutting-edge cancer therapeutics in the United States. Its clinical stage product...
Healthcare Biotechnology NASDAQ 11-50San Diego-based biotechnology company Cidara Therapeutics Inc. focuses on the development and commercialisation of long-acting anti-infectives for the treatment and prevention of infectious disease...
Healthcare Biotechnology NASDAQ 51-200Jazz Pharmaceuticals plc, a biopharmaceutical company based in Dublin, Ireland, is making waves in the field of pharmaceutical products for unmet medical needs. With a focus on neuroscience and onc...
Healthcare Biotechnology NASDAQ 501-1000Clinical-stage biopharmaceutical company Tonix Pharmaceuticals Holding Corp. is dedicated to developing cutting-edge therapeutics and vaccines that can treat and prevent a wide range of human disea...
Healthcare Biotechnology NASDAQ 11-50Medicenna, a clinical stage immunotherapy company, is focusing on developing new versions of IL-2, IL-4, and IL-13 Superkines, and Empowered Cytokines™ (ECs) for cancer treatment. The company's lea...
Healthcare Biotechnology TSX 1-10Cerus Corporation, a biomedical products company, is committed to developing and commercializing its proprietary technology, the INTERCEPT Blood System, to enhance blood safety. The company's innov...
Healthcare Biotechnology NASDAQ 201-500Abcam plc is a UK-based company that specializes in the development, marketing and distribution of antibodies and other related products. The company sells its products globally through its online ...
Healthcare Biotechnology LSE 1001-5000Chicago-based Exicure Inc., an early-phase biotech firm, is working on developing nucleic acid therapies using ribonucleic acid to target validated goals. Their preclinical drug candidate features ...
Healthcare Biotechnology NASDAQ 11-50Bellicum Pharmaceuticals, Inc. is making strides in the biopharmaceutical industry as it focuses on the development of innovative cellular immunotherapies for hematological cancers and solid tumors...
Healthcare Biotechnology NASDAQ 51-200Constellation Pharmaceuticals is a biopharmaceutical company working to address unmet medical needs in cancer patients by selectively modulating gene expression. The company's focus is on epigeneti...
Healthcare Biotechnology NASDAQ 51-200Open Orphan Limited is a niche CRO pharmaceutical services group that specializes in testing vaccines and antivirals through human challenge clinical trials. It is a world leader in this area and o...
Healthcare Biotechnology LSE 51-200ReNeuron Group plc is a UK-based company that specializes in cell-based therapies. Their flagship product is the CTX stem cell therapy candidate, which is currently in the partnering stage in China...
Healthcare Biotechnology LSE 11-50TCR2 Therapeutics Inc., a clinical-stage cell therapy company, is tackling cancer head-on with its groundbreaking T cell receptor (TCR) therapies. The company's lead product, gavo-cel, is a mono TC...
Healthcare Biotechnology NASDAQ 51-200Ardelyx Inc., a biopharmaceutical firm, has been making strides in discovering, developing, and selling medicines to address therapeutic areas in gastrointestinal and cardiorenal care both domestic...
Healthcare Biotechnology NASDAQ 51-200